Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | NQO2 | P16083 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.53 |
| ▸ | GPR3 | P46089 | 1/20 | 0.52 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30807999 | 0.79 | KDM4E (0.66) | KDM4ENQO2HSD17B10GPR3KAT2B | |
| SCHEMBL16247849 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10MEN1KMT2A | |
| SCHEMBL19326885 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10MEN1KMT2A | |
| SCHEMBL9499068 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10MEN1KMT2A | |
| SCHEMBL12090570 | 0.78 | NQO2 (0.65) | KDM4ENQO2HSD17B10MEN1KMT2A | |
| SCHEMBL30557144 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10KMT2AGPR3 | |
| SCHEMBL21831728 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10KMT2AGPR3 | |
| SCHEMBL29891972 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10KMT2AGPR3 | |
| SCHEMBL835056 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10MEN1KMT2A | |
| SCHEMBL829976 | 0.78 | KDM4E (0.65) | KDM4ENQO2HSD17B10KMT2AGPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4418865-B1 | LIQUID COMPOSITION CONTAINING A COMBINATION OF VITAMINS A, D, E AND K IN A LIQUID MATRIX | LIPOID GMBH (DE) | 2025-12-10 | — | — | EP | claimed |
| EP-3400260-B2 | SCAVENGER COMPOSITIONS FOR SULFUR SPECIES | INNOPHOS INC (US) | 2025-03-19 | — | — | EP | claimed |
| EP-3721862-B1 | ORAL CARE PREPARATIONS COMPRISING CHLORHEXIDINE AND ARGININE OR THEIR SALTS | MEDA AB (SE) | 2024-07-24 | — | — | EP | claimed |
| EP-3359138-B1 | DIETARY SUPPLEMENTATION TO ACHIEVE OXY-REDOX HOMEOSTASIS AND EPIGENETIC STABILITY | PARTHENOGEN SAGL (CH) | 2024-04-24 | — | — | EP | claimed |
| EP-3691621-B1 | NEUPANEX ®: NEUROPROTECTIVE, NEUROREGENERATIONAL,&NEUROGENESIS SUPPORTING SUPPLEMENT COMBINATION | KILMAN CLARKE LEWIS (US) | 2024-03-27 | — | — | EP | claimed |
| EP-3534915-B1 | GAMMA-POLYGLUTAMIC ACID AND ZINC COMPOSITIONS | XYLONIX PTE LTD (SG) | 2023-12-20 | — | — | EP | claimed |
| EP-3065746-B1 | ORAL REHYDRATION COMPOSITION | UNIV YALE (US) | 2023-03-08 | — | — | EP | claimed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | claimed |
| EP-4595708-A1 | PLASMA TREATMENT WITH LIQUID COOLING | Plasmatreat GmbH (DE) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024206937-A3 | BI-ARYL METHYLATED LACTAM DERIVATIVES AND RELATED COMPOSITIONS AND METHOD OF USE TO INHIBIT THE PROLIFERATION OF CANCEROUS CELLS | PURDUE RESEARCH FOUNDATION (US) | 2024-10-31 | — | — | WO | disclosed |
| CN-115677576-B | 3-Chloro-substituted quinolinone derivative and preparation method thereof | 浙江树人学院 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024068623-A1 | PLASMA TREATMENT WITH LIQUID COOLING | PLASMATREAT GMBH (DE) | 2024-04-04 | — | — | WO | disclosed |
| WO-2023067192-A1 | METHODS FOR IMPROVING ABIOTIC STRESS RESISTANCE | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-04-27 | — | — | WO | disclosed |
| US-5658751-A | SUBSTITUENTS ON PYRIDINIUM OR QUINOLINIUM RING SYSTEM SERVE TO INCREASE OR DECREASE PERMEABILITY, SELECTIVITY AND BINDING AFFINITY OF NUCLEIC ACID STAINS; FORM FLUORESCENT COMPLEXES WITH NUCLEIC ACIDS | MOLECULAR PROBES, INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5656449-A | STAINING NUCLEIC ACIDS | MOLECULAR PROBES, INC. (US) | 1997-08-12 | — | — | US | disclosed |
| WO-1996013552-A2 | SUBSTITUTED UNSYMMETRICAL CYANINE DYES WITH SELECTED PERMEABILITY | MOLECULAR PROBES, INC. (US) | 1996-05-09 | — | — | WO | disclosed |
| EP-0675924-A1 | CYCLIC-SUBSTITUTED UNSYMMETRICAL CYANINE DYES | MOLECULAR PROBES, INC. (US) | 1995-10-11 | — | — | EP | disclosed |
| US-5436134-A | Fluorescent dyes for nucleic acids | MOLECULAR PROBES, INC. (US) | 1995-07-25 | — | — | US | disclosed |
| WO-1994024213-A1 | CYCLIC-SUBSTITUTED UNSYMMETRICAL CYANINE DYES | MOLECULAR PROBES, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | KDM4E 3025/4885NQO2 243/4885HSD17B10 639/4885 |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | CBR1, POR, CAT | KDM4E 3242/4885NQO2 259/4885HSD17B10 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.